Mizuho Securities analyst Graig Suvannavejh has maintained their bullish stance on ALEC stock, giving a Buy rating today ... supports its ongoing research and development efforts, providing a buffer ...

Amgen Inc.’s stock AMGN tumbled 7.8% in early trade Tuesday, after the company said a mid-stage trial of its weight-loss ...

Analysts were expecting the treatment to achieve an average weight loss of about 20% to 25% after one year of treatment, ...

The company reported a Phase 2 study of its injectable MariTide medicine showed an approximately 20% average weight loss over one year for patients who were obese or overweight without diabetes. In ...

Amgen's experimental drug MariTide led to an average weight loss of up to 20% in a year-long mid-stage trial of nearly 600 ...

Study subjects taking the company’s MariTide lost about 20% of their weight in the 52-week trial.

Amgen stock was dropping in premarket trading after releasing data from a Phase 2 study for its experimental weight-loss drug ...

If you can stand up from the congestion of XM4, then you can try out Model L, which is also a great option in Call of Duty: ...

Black Ops 6 Season 1, the new iteration of Warzone is now out. With a new Resurgence map and rework mechanics, the popular Battle Royale title also comes with new Dark Ops Challenges. These challenges ...

The Biden-Harris Administration has proposed a new rule to expand coverage of anti-obesity medications for Americans with Medicare and ...

The stocks of companies that make the new class of drugs to treat obesity and manage diabetes were higher across the board ...